Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Being overweight can cause or worsen skin problems in children, some more common in darker skin, and is often linked to insulin resistance.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

Lizards can regrow their tail scales with the same structure, distribution, and gender-specific features as the original ones, and this unique ability is not seen in adult mammals.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Baricitinib is effective for severe alopecia areata but has some side effects.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

CCCA can affect both genders and all ages, and it has a genetic component.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Most medical students in the study had skin and hair issues, with acne, hair loss, and sun tan being common, and these issues varied by gender and origin.

Vaccination and timely treatment reduce the risk of long COVID.

Chemotherapy can cause permanent hair loss.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Tinea incognito in Iran commonly affects adults and mimics other skin conditions.

Hirsutism perception varies by culture and individual.

Hair loss in young adults is linked to harder arteries.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

NIH dermatology funding increased by 14.7% from 2015 to 2019, but men and certain states and institutions received most of the money.